Velsta

Velsta

Manufacturer:

Bafna Pharma

Distributor:

Multicare
Concise Prescribing Info
Contents
Montelukast Na 10 mg, levocetirizine diHCl 5 mg
Indications/Uses
Chronic allergic conditions eg, seasonal allergic rhinitis, perennial allergic rhinitis, rhinitis associated w/ asthma.
Dosage/Direction for Use
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to montelukast Na, levocetirizine or cetirizine. Severe renal impairment (CrCl <10 mL/min). Galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption.
Special Precautions
Pregnancy & lactation. Elderly. Montelukast: Not indicated for the reversal of bronchospasm in acute asthma attacks, including status asthmaticus. Do not abruptly substitute for inhaled or oral corticosteroids. Do not use as monotherapy for the treatment & management of exercise-induced bronchospasm. Avoid in patients w/ known aspirin sensitivity. Hepatic impairment. Levocetirizine diHCl: Alcohol intake. Renal impairment. May impair ability to drive or operate machinery.
Adverse Reactions
Montelukast: Dyspepsia, abdominal pain, rash, dizziness, headache, fatigue, fever, trauma, cough, nasal congestion, flu. Levocetirizine diHCl: Somnolence, fatigue, nasopharyngitis, dry mouth & pharyngitis.
Drug Interactions
Montelukast: Potent CYP450 inducers eg, phenobarb or rifampin.
MIMS Class
Antihistamines & Antiallergics / Antiasthmatic & COPD Preparations
ATC Classification
R03DC53 - montelukast, combinations ; Belongs to the class of leukotriene receptor antagonists. Used in the systemic treatment of obstructive airway diseases.
Presentation/Packing
Form
Velsta FC tab
Packing/Price
30's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in